Brief: Cidara Therapeutics Announces Completion Of Enrollment In Phase 3 Restore Trial Of Rezafungin In China

Cidara Therapeutics

06/12/2023 13:19

Dec 6 (Reuters) - Cidara Therapeutics Inc  CDTX.O :
    * CIDARA THERAPEUTICS ANNOUNCES COMPLETION OF ENROLLMENT IN
PHASE
3 RESTORE TRIAL OF REZAFUNGIN IN CHINA
    * CIDARA THERAPEUTICS INC - TOP-LINE DATA EXPECTED IN Q2
2024
    * CIDARA THERAPEUTICS: TRIAL COMPLETION TO REDUCE CASH BURN
LONGER-TERM & MAKES US ELIGIBLE TO RECEIVE OTHER REGULATORY,
COMMERCIAL MILESTONE PAYMENTS

Source text for Eikon:  ID:nGNXbyb4TZ 
Further company coverage:  CDTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))